Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry - 10/02/24

Doi : 10.1016/j.jaad.2023.04.062

Anastasiya Muntyanu, MD ^a, Raymond Milan, PhD ^b, Elham Rahme, PhD ^b,^c, Murray Baron, MD ^d, Elena Netchiporouk, MD, MSc ^e,^⁎
and the
Canadian Scleroderma Research Group^∗
Investigators of the Canadian Scleroderma Research Group: M. Baron, Montreal, Quebec; M. Hudson, Montreal, Quebec; G. Gyger, Montreal, Quebec; J. Pope, London, Ontario; M. Larche, Hamilton, Ontario; N. Khalidi, Hamilton, Ontario; A. Masetto, Sherbrooke, Quebec; E. Sutton, Halifax, Nova Scotia; T. S. Rodriguez Reyna, Mexico City, Mexico; N. Maltez, Ottawa, Ontario; C. Thorne, Newmarket, Ontario; P. R. Fortin, Quebec, Quebec; A. Ikic, Quebec, Quebec; D. Robinson, Winnipeg, Manitoba; N. Jones, Edmonton, Alberta; S. LeClercq, Calgary, Alberta; P. Docherty, Moncton, New Brunswick; D. Smith, Ottawa, Ontario; M. J. Fritzler, Department of Medicine, Cumming School of Medicine, Calgary, Alberta; and E. Kaminska, Calgary, Alberta.
M. Baron, M. Hudson, G. Gyger, J. Pope, M. Larche, N. Khalidi, A. Masetto, E. Sutton, T.S. Rodriguez Reyna, N. Maltez, C. Thorne, P.R. Fortin, A. Ikic, D. Robinson, N. Jones, S. LeClercq, P. Docherty, D. Smith, M.J. Fritzler, E. Kaminska

^a Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada
^b Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
^c Department of Medicine, Division of Clinical Epidemiology, McGill University, Montreal, Quebec, Canada
^d Division of Rheumatology, Department of Medicine, Jewish General Hospital, Montreal, Quebec, Canada
^e Division of Dermatology, Department of Medicine, McGill University Health Centre, Montreal General Hospital, Montreal, Quebec, Canada

^∗Correspondence to: Elena Netchiporouk, MD, MSc, FRCPC, Division of Dermatology, Department of Medicine, McGill University Health Centre, Montreal General Hospital, 1650 Cedar Avenue, Montreal, Quebec, Canada H3G 1A4Division of DermatologyDepartment of MedicineMcGill University Health CentreMontreal General Hospital1650 Cedar AvenueMontrealQuebecH3G 1A4Canada

Key words : disease severity, environmental triggers, mortality, occupation, organic solvents, systemic sclerosis

	Funding sources: Association des Médecins Spécialistes Dermatologues du Québec and Canadian Dermatology Foundation grants to Drs Netchiporouk and Muntyanu.
	IRB approval status: Ethics approval for this study was obtained at the Jewish General Hospital, Montreal, Quebec, Canada and at all participating CSRG study sites.
	Patient consent: Not applicable.

Export

Vol 90 - N° 3

P. 605-607 - mars 2024 Retour au numéro

Article précédent

Unmet needs for patients with seborrheic dermatitis
J. Mark Jackson, Andrew Alexis, Matthew Zirwas, Susan Taylor

| Article suivant

Association between alopecia areata and atopic dermatitis: A nested case-control study of the All of Us database
Michael J. Diaz, Zaim Haq, Parsa Abdi, Jasmine T. Tran, Emma Guttman-Yassky, Benjamin Ungar

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry - 10/02/24

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL